nitroglycerin has been researched along with Delayed Postpartum Hemorrhage in 9 studies
Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.
Excerpt | Relevance | Reference |
---|---|---|
"Intravenous nitroglycerin and combined spinal-epidural anesthesia may offer an alternative to GA for achieving uterine relaxation in patients with PPP and a predicted difficult airway undergoing PTUI CS to control postpartum hemorrhage." | 9.05 | Use of nitroglycerin for parallel transverse uterine cesarean section in patients with pernicious placenta previa and placenta accrete and predicted difficult airway: A case report and review of literature. ( Jiang, X; Lin, X; Ma, Y; You, Y, 2020) |
"After these two UAE procedures, no recurrence of bleeding was observed." | 5.42 | Use of intra-arterial nitroglycerin during uterine artery embolization for severe postpartum hemorrhage with uterine artery vasospasm. ( Chiba, E; Hamamoto, K; Horiuchi, I; Matsuura, K; Mikami, Y; Okochi, T; Takagi, K; Wang, L, 2015) |
"Intravenous nitroglycerin and combined spinal-epidural anesthesia may offer an alternative to GA for achieving uterine relaxation in patients with PPP and a predicted difficult airway undergoing PTUI CS to control postpartum hemorrhage." | 5.05 | Use of nitroglycerin for parallel transverse uterine cesarean section in patients with pernicious placenta previa and placenta accrete and predicted difficult airway: A case report and review of literature. ( Jiang, X; Lin, X; Ma, Y; You, Y, 2020) |
" Nitroglycerin administration was not associated with an increase in headaches (RR 1." | 4.91 | Nitroglycerin for management of retained placenta. ( Abdel-Aleem, H; Abdel-Aleem, MA; Shaaban, OM, 2015) |
"Currently, the only effective treatments for a retained placenta are the surgical procedures of manual removal of placenta (MROP) and uterine curettage, which are not universally available, particularly in low- and middle-income countries." | 2.90 | Nitroglycerin for treatment of retained placenta: A randomised, placebo-controlled, multicentre, double-blind trial in the UK. ( Brewin, J; Carruthers, KF; Chua, GN; Denison, FC; Hallowell, N; Hudson, J; Lawton, J; McPherson, G; Norman, JE; Norrie, J; Peace, M; Scotland, G, 2019) |
"The only way to treat a retained placenta is for a trained doctor to remove it by an operation in theatre." | 2.90 | Glyceryl trinitrate to reduce the need for manual removal of retained placenta following vaginal delivery: the GOT-IT RCT. ( Brewin, J; Brook-Smith, S; Carruthers, KF; Chua, GN; Clarkson, C; Denison, FC; Hallowell, N; Hudson, J; Lawton, J; McPherson, G; Norman, JE; Norrie, J; Peace, M; Scotland, G, 2019) |
"A retained placenta is diagnosed when the placenta is not delivered following delivery of the baby." | 2.84 | A pragmatic group sequential, placebo-controlled, randomised trial to determine the effectiveness of glyceryl trinitrate for retained placenta (GOT-IT): a study protocol. ( Brewin, J; Brook-Smith, S; Carruthers, KF; Clarkson, C; Denison, FC; Forrest, M; Hallowell, N; Hodges, L; Hudson, J; Lawton, J; McDonald, A; McPherson, GC; Morrow, S; Norman, JE; Norrie, J; Peace, M; Scotland, G, 2017) |
"The rates of successful removal of the retained placenta in the study (n=20) and control (n=20) groups were compared, as were blood pressure, pulse rate, blood loss, and adverse effects." | 2.76 | Intravenous nitroglycerin for controlled cord traction in the management of retained placenta. ( Permpolprasert, L; Prechapanich, J; Suksopee, P; Suwanvichai, S; Visalyaputra, S; Yimyam, S, 2011) |
"After these two UAE procedures, no recurrence of bleeding was observed." | 1.42 | Use of intra-arterial nitroglycerin during uterine artery embolization for severe postpartum hemorrhage with uterine artery vasospasm. ( Chiba, E; Hamamoto, K; Horiuchi, I; Matsuura, K; Mikami, Y; Okochi, T; Takagi, K; Wang, L, 2015) |
"Postpartum haemorrhage due to retained placenta is one of the commonest life-threatening conditions during the third stage of labour." | 1.32 | Intravenous nitro-glycerine versus general anaesthesia for placental extraction--a sequential comparison. ( Chiu, JW; Jha, S; Yeo, IS, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 7 (77.78) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Denison, FC | 3 |
Carruthers, KF | 3 |
Hudson, J | 3 |
McPherson, G | 2 |
Chua, GN | 2 |
Peace, M | 3 |
Brewin, J | 3 |
Hallowell, N | 3 |
Scotland, G | 3 |
Lawton, J | 3 |
Norrie, J | 3 |
Norman, JE | 3 |
Brook-Smith, S | 2 |
Clarkson, C | 2 |
Ma, Y | 1 |
You, Y | 1 |
Jiang, X | 1 |
Lin, X | 1 |
McPherson, GC | 1 |
McDonald, A | 1 |
Forrest, M | 1 |
Morrow, S | 1 |
Hodges, L | 1 |
Wang, L | 1 |
Horiuchi, I | 1 |
Mikami, Y | 1 |
Takagi, K | 1 |
Okochi, T | 1 |
Hamamoto, K | 1 |
Chiba, E | 1 |
Matsuura, K | 1 |
Abdel-Aleem, H | 1 |
Abdel-Aleem, MA | 1 |
Shaaban, OM | 1 |
Isquick, S | 1 |
Henry, D | 1 |
Nakagawa, S | 1 |
Moghadassi, M | 1 |
Thiet, MP | 1 |
Norton, M | 1 |
Lucero, J | 1 |
Visalyaputra, S | 1 |
Prechapanich, J | 1 |
Suwanvichai, S | 1 |
Yimyam, S | 1 |
Permpolprasert, L | 1 |
Suksopee, P | 1 |
Jha, S | 1 |
Chiu, JW | 1 |
Yeo, IS | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
GOT-IT Trial: A Pragmatic Group Sequential Placebo Controlled Randomised Trial to Determine the Effectiveness of Glyceryl Trinitrate for Retained Placenta.[NCT02085213] | Phase 4 | 1,107 participants (Actual) | Interventional | 2014-09-30 | Completed | ||
Randomized Controlled Trial of IV Nitroglycerin in Cesarean Deliveries After Second Stage Arrest for the Prevention of Uterine Extension[NCT02265965] | Phase 4 | 18 participants (Actual) | Interventional | 2015-10-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
The APGAR scale is determined by evaluating the newborn baby on five simple criteria -- Appearance, Pulse, Grimace, Activity, Respiration -- on a scale from zero to two, then summing up the five values thus obtained. The resulting APGAR score ranges from zero to 10. Zero is the worst possible score and 10 is the highest possible score. (NCT02265965)
Timeframe: Immediately after cesarean delivery, estimated to be within 4 hours after diagnosis of second stage arrest
Intervention | score on a scale (Median) |
---|---|
Intravenous Nitroglycerin | 9 |
Intravenous Saline | 9 |
Time from uterine incision to delivery (body of neonate fully extracted from uterus) (NCT02265965)
Timeframe: At time of cesarean delivery, estimated to be within 4 hours after diagnosis of second stage arrest
Intervention | seconds (Mean) |
---|---|
Intravenous Nitroglycerin | 104.9 |
Intravenous Saline | 131 |
(NCT02265965)
Timeframe: After cesarean delivery, estimated to be within 4 hours after diagnosis of second stage arrest
Intervention | Participants (Count of Participants) |
---|---|
Intravenous Nitroglycerin | 1 |
Intravenous Saline | 2 |
A cord blood base deficit more negative than negative 12 is abnormal and a sign of metabolic acidosis. (NCT02265965)
Timeframe: At time of cesarean delivery, estimated to be within 4 hours after diagnosis of second stage arrest
Intervention | Participants (Count of Participants) |
---|---|
Intravenous Nitroglycerin | 7 |
Intravenous Saline | 11 |
Obstetrician determined whether the subject had an uterine extension. (NCT02265965)
Timeframe: During cesarean delivery, estimated to be within 4 hours after diagnosis of second stage arrest
Intervention | Participants (Count of Participants) |
---|---|
Intravenous Nitroglycerin | 3 |
Intravenous Saline | 4 |
Total blood loss will be measured (NCT02265965)
Timeframe: During and after cesarean delivery, estimated to be within 4 hours after diagnosis of second stage arrest
Intervention | ml (Mean) |
---|---|
Intravenous Nitroglycerin | 935.7 |
Intravenous Saline | 1036.4 |
Time from uterine incision to out of room (NCT02265965)
Timeframe: After cesarean delivery, estimated to be within 4 hours after diagnosis of second stage arrest
Intervention | minutes (Mean) |
---|---|
Intravenous Nitroglycerin | 68.3 |
Intravenous Saline | 74.2 |
Measure of umbilical artery blood pH (NCT02265965)
Timeframe: At time of cesarean delivery, estimated to be within 4 hours after diagnosis of second stage arrest
Intervention | pH (Mean) |
---|---|
Intravenous Nitroglycerin | 7.3 |
Intravenous Saline | 7.3 |
2 reviews available for nitroglycerin and Delayed Postpartum Hemorrhage
Article | Year |
---|---|
Use of nitroglycerin for parallel transverse uterine cesarean section in patients with pernicious placenta previa and placenta accrete and predicted difficult airway: A case report and review of literature.
Topics: Administration, Intravenous; Adult; Cesarean Section; Female; Humans; Nitroglycerin; Placenta Accret | 2020 |
Nitroglycerin for management of retained placenta.
Topics: Administration, Sublingual; Female; Headache; Humans; Nitroglycerin; Oxytocics; Oxytocin; Placenta, | 2015 |
4 trials available for nitroglycerin and Delayed Postpartum Hemorrhage
Article | Year |
---|---|
Nitroglycerin for treatment of retained placenta: A randomised, placebo-controlled, multicentre, double-blind trial in the UK.
Topics: Administration, Sublingual; Adult; Cost-Benefit Analysis; Delivery, Obstetric; Double-Blind Method; | 2019 |
Glyceryl trinitrate to reduce the need for manual removal of retained placenta following vaginal delivery: the GOT-IT RCT.
Topics: Administration, Sublingual; Adolescent; Adult; Blood Transfusion; Cost-Benefit Analysis; Double-Blin | 2019 |
A pragmatic group sequential, placebo-controlled, randomised trial to determine the effectiveness of glyceryl trinitrate for retained placenta (GOT-IT): a study protocol.
Topics: Administration, Sublingual; Blood Volume; Cost Savings; Cost-Benefit Analysis; Double-Blind Method; | 2017 |
Intravenous nitroglycerin for controlled cord traction in the management of retained placenta.
Topics: Adult; Blood Pressure; Female; Heart Rate; Humans; Injections, Intravenous; Nitroglycerin; Placenta, | 2011 |
3 other studies available for nitroglycerin and Delayed Postpartum Hemorrhage
Article | Year |
---|---|
Use of intra-arterial nitroglycerin during uterine artery embolization for severe postpartum hemorrhage with uterine artery vasospasm.
Topics: Adult; Cesarean Section; Combined Modality Therapy; Constriction, Pathologic; Female; Humans; Nitrog | 2015 |
The association between nitroglycerin use and adverse outcomes in women undergoing cesarean delivery in the second stage of labor.
Topics: Administration, Intravenous; Administration, Sublingual; Adult; Cesarean Section; Female; Humans; La | 2017 |
Intravenous nitro-glycerine versus general anaesthesia for placental extraction--a sequential comparison.
Topics: Anesthesia, General; Anesthesia, Intravenous; Anesthetics, Intravenous; Female; Fentanyl; Hemodynami | 2003 |